41st AGM proceedings - final dividend of Re 1 per share declared
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma held its 41st AGM on July 15, 2026 via video conferencing with 72 members attending. Resolutions tabled: adoption of audited financials for FY ending March 31, 2026, declaration of a final dividend of Re 1 per share, and re-appointment of MD Mr. Narsimha Shibroor Kamath. Both statutory and secretarial auditor reports were clean. The MD highlighted manufacturing expansion, commencement of Kenya operations, receipt of WHO inspection closure report, and 55 to 60 percent renewable energy use. E-voting results will be announced within 2 working days.
Re 1 per share final dividend benefits shareholders; clean audits and expansion signals suggest stable outlook for the company.